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LETTERS TO THE EDITOR
Management of Aortic Intramural Hematoma
We read with interest the excellent study by Song et al. (1) on
“Different Clinical Features of Aortic Intramural Hematoma
Versus Dissection Involving the Ascending Aorta.” We write to
address a limitation of this study and most other available literature
on this topic—namely, the brief follow-up time after presentation.
Our group has previously published data on the presentation
and early follow-up of intramural hematomas (2). At the recent
American Association of Thoracic Surgery meeting, we presented
a report on “Midterm Follow-up of Penetrating Ulcer and Intra-
mural Hematoma of the Aorta.” Our data agree with that of Song
et al. on several points, including the advanced age of aortic intramural
hematoma (AIH) patients (74 years) and the unusual female prepon-
derance (58%). However, the relatively long follow-up in our report
(mean of 41 months, compared to 37 days to 22 months in the
available literature) for 19 patients with acute intramural hematoma
has led us to different management recommendations. In examining
these patients over time, several factors became apparent. First,
incidence of rupture on admission is very high in AIH patients, at
26%, compared to 8% and 4%, respectively, for our type A and type
B dissections in our total dissection registry (p  0.01).
Second, in follow-up imaging of our cohort, 46% had healing, 9%
had no change, 18% had worsening and 27% had progression to frank
dissection. Therefore, 54% had either worsening or no change.
Third, the aorta continues to grow in these patients, at a rate of
0.4 cm/year.
Fourth, of the eight deaths in late follow-up in our series, fully
five (63%) were due to documented rupture.
Fifth, nonoperative survival of AIH patients (n  12) was 50%
at four years in our cohort, but with surgical intervention (n  7)
the four-year survival became 86%. Despite the advanced age and
acute nature of these patients, operative mortality was a reasonable
14%. Hence, surgical survival exceeded that of equally or less ill
medically managed patients.
Thus, our review of this data has led to a distinct change in our
policy protocols for treatment of intramural hematoma. Several years
ago when our follow-up time was short, as in the study by Song et al.
(1) (15 months), we had similar conclusions that nonoperative therapy
might suffice initially. Now that we have more solid midterm data, we
consider this virulent lesion to be surgical, if patient comorbidities
allow aggressive intervention. This paradigm shift is due to the high
rates of rupture on presentation, the frequency of worsening on serial
radiographic follow-up, and the continued incidence of death from
rupture despite medical management. Though a significant percent-
age of these lesions heal spontaneously, we believe that operative
intervention is justified owing to the high percentage of mortalities
attributable to late rupture.
Finally, Song et al. (1) have made a significant contribution with
their study, but we express caution regarding their management
guidelines because of the short follow-up times. Our own data
point to much higher virulence of this condition.
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REPLY
We appreciate the comments of Tittle et al. regarding our recent
publication (1). We agree that we are not yet ready to answer the
question as to how the natural history of intramural hematoma
differs from that of classic dissection. Tittle et al. described the
results of “midterm follow-up” of their patients, and they con-
cluded that operative intervention is justified due to high rates of
mortality and vascular complications of this “virulent” lesion. We
accept their idea that we need longer follow-up duration to derive
a meaningful conclusion about that question. However, we would
like to remind them that we are not the only investigators who
have some concerns about the strategy that all patients with
proximal aortic intramural hematoma need urgent surgical repair
(2–4). Tittle et al. reported a very high rate of delayed rupture in
these patients, which is a very unusual finding based on our limited
experience. We wonder whether any imaging study was done
regularly to check the development of potential complications or
whether they found any abnormal finding predicting the event.
Because useful noninvasive diagnostic tools for aortic pathology are
available today, serial follow-up imaging studies with longer
duration are feasible and would provide the final answer to these
questions.
Finally, we would like to remind other readers that our recent
report was a retrospective analysis of data obtained in a single
center, and our data are not so complete as to support when it is
appropriate to operate on those patients with proximal aortic
intramural hematoma. We hope our study will stimulate many
groups to reevaluate the natural history of proximal intramural
hematoma and perhaps to examine the same question in non-
Asian populations.
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